Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global RNAi Medicine Market Growth (Status and Outlook) 2022-2028

  • LP 4885957
  • 85 Pages
  • March 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of RNAi Medicine will have significant change from previous year. According to our (LP Information) latest study, the global RNAi Medicine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global RNAi Medicine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States RNAi Medicine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global RNAi Medicine market, reaching US$ million by the year 2028. As for the Europe RNAi Medicine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main RNAi Medicine players cover Alnylam Pharmaceuticals, Ionis Pharmaceuticals, Suzhou Ribo Life Science Co.,Ltd., and Sirnaomics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of RNAi Medicine market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

siRNA

miRNA

piRNA

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Drug Discovery & Development

Therapeutics

Drug Delivery

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Alnylam Pharmaceuticals

Ionis Pharmaceuticals

Suzhou Ribo Life Science Co.,Ltd.

Sirnaomics

GemmaPharma

RiboBio

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global RNAi Medicine Market Size 2017-2028

2.1.2 RNAi Medicine Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 RNAi Medicine Segment by Type

2.2.1 siRNA

2.2.2 miRNA

2.2.3 piRNA

2.2.4 Others

2.3 RNAi Medicine Market Size by Type

2.3.1 RNAi Medicine Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global RNAi Medicine Market Size Market Share by Type (2017-2022)

2.4 RNAi Medicine Segment by Application

2.4.1 Drug Discovery & Development

2.4.2 Therapeutics

2.4.3 Drug Delivery

2.4.4 Others

2.5 RNAi Medicine Market Size by Application

2.5.1 RNAi Medicine Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global RNAi Medicine Market Size Market Share by Application (2017-2022)

3 RNAi Medicine Market Size by Player

3.1 RNAi Medicine Market Size Market Share by Players

3.1.1 Global RNAi Medicine Revenue by Players (2020-2022)

3.1.2 Global RNAi Medicine Revenue Market Share by Players (2020-2022)

3.2 Global RNAi Medicine Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 RNAi Medicine by Regions

4.1 RNAi Medicine Market Size by Regions (2017-2022)

4.2 Americas RNAi Medicine Market Size Growth (2017-2022)

4.3 APAC RNAi Medicine Market Size Growth (2017-2022)

4.4 Europe RNAi Medicine Market Size Growth (2017-2022)

4.5 Middle East & Africa RNAi Medicine Market Size Growth (2017-2022)

5 Americas

5.1 Americas RNAi Medicine Market Size by Country (2017-2022)

5.2 Americas RNAi Medicine Market Size by Type (2017-2022)

5.3 Americas RNAi Medicine Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC RNAi Medicine Market Size by Region (2017-2022)

6.2 APAC RNAi Medicine Market Size by Type (2017-2022)

6.3 APAC RNAi Medicine Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe RNAi Medicine by Country (2017-2022)

7.2 Europe RNAi Medicine Market Size by Type (2017-2022)

7.3 Europe RNAi Medicine Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa RNAi Medicine by Region (2017-2022)

8.2 Middle East & Africa RNAi Medicine Market Size by Type (2017-2022)

8.3 Middle East & Africa RNAi Medicine Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global RNAi Medicine Market Forecast

10.1 Global RNAi Medicine Forecast by Regions (2023-2028)

10.1.1 Global RNAi Medicine Forecast by Regions (2023-2028)

10.1.2 Americas RNAi Medicine Forecast

10.1.3 APAC RNAi Medicine Forecast

10.1.4 Europe RNAi Medicine Forecast

10.1.5 Middle East & Africa RNAi Medicine Forecast

10.2 Americas RNAi Medicine Forecast by Country (2023-2028)

10.2.1 United States RNAi Medicine Market Forecast

10.2.2 Canada RNAi Medicine Market Forecast

10.2.3 Mexico RNAi Medicine Market Forecast

10.2.4 Brazil RNAi Medicine Market Forecast

10.3 APAC RNAi Medicine Forecast by Region (2023-2028)

10.3.1 China RNAi Medicine Market Forecast

10.3.2 Japan RNAi Medicine Market Forecast

10.3.3 Korea RNAi Medicine Market Forecast

10.3.4 Southeast Asia RNAi Medicine Market Forecast

10.3.5 India RNAi Medicine Market Forecast

10.3.6 Australia RNAi Medicine Market Forecast

10.4 Europe RNAi Medicine Forecast by Country (2023-2028)

10.4.1 Germany RNAi Medicine Market Forecast

10.4.2 France RNAi Medicine Market Forecast

10.4.3 UK RNAi Medicine Market Forecast

10.4.4 Italy RNAi Medicine Market Forecast

10.4.5 Russia RNAi Medicine Market Forecast

10.5 Middle East & Africa RNAi Medicine Forecast by Region (2023-2028)

10.5.1 Egypt RNAi Medicine Market Forecast

10.5.2 South Africa RNAi Medicine Market Forecast

10.5.3 Israel RNAi Medicine Market Forecast

10.5.4 Turkey RNAi Medicine Market Forecast

10.5.5 GCC Countries RNAi Medicine Market Forecast

10.6 Global RNAi Medicine Forecast by Type (2023-2028)

10.7 Global RNAi Medicine Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Alnylam Pharmaceuticals

11.1.1 Alnylam Pharmaceuticals Company Information

11.1.2 Alnylam Pharmaceuticals RNAi Medicine Product Offered

11.1.3 Alnylam Pharmaceuticals RNAi Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Alnylam Pharmaceuticals Main Business Overview

11.1.5 Alnylam Pharmaceuticals Latest Developments

11.2 Ionis Pharmaceuticals

11.2.1 Ionis Pharmaceuticals Company Information

11.2.2 Ionis Pharmaceuticals RNAi Medicine Product Offered

11.2.3 Ionis Pharmaceuticals RNAi Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Ionis Pharmaceuticals Main Business Overview

11.2.5 Ionis Pharmaceuticals Latest Developments

11.3 Suzhou Ribo Life Science Co.,Ltd.

11.3.1 Suzhou Ribo Life Science Co.,Ltd. Company Information

11.3.2 Suzhou Ribo Life Science Co.,Ltd. RNAi Medicine Product Offered

11.3.3 Suzhou Ribo Life Science Co.,Ltd. RNAi Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Suzhou Ribo Life Science Co.,Ltd. Main Business Overview

11.3.5 Suzhou Ribo Life Science Co.,Ltd. Latest Developments

11.4 Sirnaomics

11.4.1 Sirnaomics Company Information

11.4.2 Sirnaomics RNAi Medicine Product Offered

11.4.3 Sirnaomics RNAi Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Sirnaomics Main Business Overview

11.4.5 Sirnaomics Latest Developments

11.5 GemmaPharma

11.5.1 GemmaPharma Company Information

11.5.2 GemmaPharma RNAi Medicine Product Offered

11.5.3 GemmaPharma RNAi Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 GemmaPharma Main Business Overview

11.5.5 GemmaPharma Latest Developments

11.6 RiboBio

11.6.1 RiboBio Company Information

11.6.2 RiboBio RNAi Medicine Product Offered

11.6.3 RiboBio RNAi Medicine Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 RiboBio Main Business Overview

11.6.5 RiboBio Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. RNAi Medicine Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of siRNA

Table 3. Major Players of miRNA

Table 4. Major Players of piRNA

Table 5. Major Players of Others

Table 6. RNAi Medicine Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 7. Global RNAi Medicine Market Size by Type (2017-2022) & ($ Millions)

Table 8. Global RNAi Medicine Market Size Market Share by Type (2017-2022)

Table 9. RNAi Medicine Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 10. Global RNAi Medicine Market Size by Application (2017-2022) & ($ Millions)

Table 11. Global RNAi Medicine Market Size Market Share by Application (2017-2022)

Table 12. Global RNAi Medicine Revenue by Players (2020-2022) & ($ Millions)

Table 13. Global RNAi Medicine Revenue Market Share by Player (2020-2022)

Table 14. RNAi Medicine Key Players Head office and Products Offered

Table 15. RNAi Medicine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global RNAi Medicine Market Size by Regions 2017-2022 & ($ Millions)

Table 19. Global RNAi Medicine Market Size Market Share by Regions (2017-2022)

Table 20. Americas RNAi Medicine Market Size by Country (2017-2022) & ($ Millions)

Table 21. Americas RNAi Medicine Market Size Market Share by Country (2017-2022)

Table 22. Americas RNAi Medicine Market Size by Type (2017-2022) & ($ Millions)

Table 23. Americas RNAi Medicine Market Size Market Share by Type (2017-2022)

Table 24. Americas RNAi Medicine Market Size by Application (2017-2022) & ($ Millions)

Table 25. Americas RNAi Medicine Market Size Market Share by Application (2017-2022)

Table 26. APAC RNAi Medicine Market Size by Region (2017-2022) & ($ Millions)

Table 27. APAC RNAi Medicine Market Size Market Share by Region (2017-2022)

Table 28. APAC RNAi Medicine Market Size by Type (2017-2022) & ($ Millions)

Table 29. APAC RNAi Medicine Market Size Market Share by Type (2017-2022)

Table 30. APAC RNAi Medicine Market Size by Application (2017-2022) & ($ Millions)

Table 31. APAC RNAi Medicine Market Size Market Share by Application (2017-2022)

Table 32. Europe RNAi Medicine Market Size by Country (2017-2022) & ($ Millions)

Table 33. Europe RNAi Medicine Market Size Market Share by Country (2017-2022)

Table 34. Europe RNAi Medicine Market Size by Type (2017-2022) & ($ Millions)

Table 35. Europe RNAi Medicine Market Size Market Share by Type (2017-2022)

Table 36. Europe RNAi Medicine Market Size by Application (2017-2022) & ($ Millions)

Table 37. Europe RNAi Medicine Market Size Market Share by Application (2017-2022)

Table 38. Middle East & Africa RNAi Medicine Market Size by Region (2017-2022) & ($ Millions)

Table 39. Middle East & Africa RNAi Medicine Market Size Market Share by Region (2017-2022)

Table 40. Middle East & Africa RNAi Medicine Market Size by Type (2017-2022) & ($ Millions)

Table 41. Middle East & Africa RNAi Medicine Market Size Market Share by Type (2017-2022)

Table 42. Middle East & Africa RNAi Medicine Market Size by Application (2017-2022) & ($ Millions)

Table 43. Middle East & Africa RNAi Medicine Market Size Market Share by Application (2017-2022)

Table 44. Key Market Drivers & Growth Opportunities of RNAi Medicine

Table 45. Key Market Challenges & Risks of RNAi Medicine

Table 46. Key Industry Trends of RNAi Medicine

Table 47. Global RNAi Medicine Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 48. Global RNAi Medicine Market Size Market Share Forecast by Regions (2023-2028)

Table 49. Global RNAi Medicine Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 50. Global RNAi Medicine Market Size Market Share Forecast by Type (2023-2028)

Table 51. Global RNAi Medicine Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 52. Global RNAi Medicine Market Size Market Share Forecast by Application (2023-2028)

Table 53. Alnylam Pharmaceuticals Details, Company Type, RNAi Medicine Area Served and Its Competitors

Table 54. Alnylam Pharmaceuticals RNAi Medicine Product Offered

Table 55. Alnylam Pharmaceuticals RNAi Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 56. Alnylam Pharmaceuticals Main Business

Table 57. Alnylam Pharmaceuticals Latest Developments

Table 58. Ionis Pharmaceuticals Details, Company Type, RNAi Medicine Area Served and Its Competitors

Table 59. Ionis Pharmaceuticals RNAi Medicine Product Offered

Table 60. Ionis Pharmaceuticals Main Business

Table 61. Ionis Pharmaceuticals RNAi Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 62. Ionis Pharmaceuticals Latest Developments

Table 63. Suzhou Ribo Life Science Co.,Ltd. Details, Company Type, RNAi Medicine Area Served and Its Competitors

Table 64. Suzhou Ribo Life Science Co.,Ltd. RNAi Medicine Product Offered

Table 65. Suzhou Ribo Life Science Co.,Ltd. Main Business

Table 66. Suzhou Ribo Life Science Co.,Ltd. RNAi Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 67. Suzhou Ribo Life Science Co.,Ltd. Latest Developments

Table 68. Sirnaomics Details, Company Type, RNAi Medicine Area Served and Its Competitors

Table 69. Sirnaomics RNAi Medicine Product Offered

Table 70. Sirnaomics Main Business

Table 71. Sirnaomics RNAi Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 72. Sirnaomics Latest Developments

Table 73. GemmaPharma Details, Company Type, RNAi Medicine Area Served and Its Competitors

Table 74. GemmaPharma RNAi Medicine Product Offered

Table 75. GemmaPharma Main Business

Table 76. GemmaPharma RNAi Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 77. GemmaPharma Latest Developments

Table 78. RiboBio Details, Company Type, RNAi Medicine Area Served and Its Competitors

Table 79. RiboBio RNAi Medicine Product Offered

Table 80. RiboBio Main Business

Table 81. RiboBio RNAi Medicine Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 82. RiboBio Latest Developments

List of Figures

Figure 1. RNAi Medicine Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global RNAi Medicine Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global RNAi Medicine Market Size Market Share by Type in 2021

Figure 7. RNAi Medicine in Drug Discovery & Development

Figure 8. Global RNAi Medicine Market: Drug Discovery & Development (2017-2022) & ($ Millions)

Figure 9. RNAi Medicine in Therapeutics

Figure 10. Global RNAi Medicine Market: Therapeutics (2017-2022) & ($ Millions)

Figure 11. RNAi Medicine in Drug Delivery

Figure 12. Global RNAi Medicine Market: Drug Delivery (2017-2022) & ($ Millions)

Figure 13. RNAi Medicine in Others

Figure 14. Global RNAi Medicine Market: Others (2017-2022) & ($ Millions)

Figure 15. Global RNAi Medicine Market Size Market Share by Application in 2021

Figure 16. Global RNAi Medicine Revenue Market Share by Player in 2021

Figure 17. Global RNAi Medicine Market Size Market Share by Regions (2017-2022)

Figure 18. Americas RNAi Medicine Market Size 2017-2022 ($ Millions)

Figure 19. APAC RNAi Medicine Market Size 2017-2022 ($ Millions)

Figure 20. Europe RNAi Medicine Market Size 2017-2022 ($ Millions)

Figure 21. Middle East & Africa RNAi Medicine Market Size 2017-2022 ($ Millions)

Figure 22. Americas RNAi Medicine Value Market Share by Country in 2021

Figure 23. Americas RNAi Medicine Consumption Market Share by Type in 2021

Figure 24. Americas RNAi Medicine Market Size Market Share by Application in 2021

Figure 25. United States RNAi Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 26. Canada RNAi Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 27. Mexico RNAi Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 28. Brazil RNAi Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 29. APAC RNAi Medicine Market Size Market Share by Region in 2021

Figure 30. APAC RNAi Medicine Market Size Market Share by Application in 2021

Figure 31. China RNAi Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 32. Japan RNAi Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 33. Korea RNAi Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 34. Southeast Asia RNAi Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 35. India RNAi Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 36. Australia RNAi Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 37. Europe RNAi Medicine Market Size Market Share by Country in 2021

Figure 38. Europe RNAi Medicine Market Size Market Share by Type in 2021

Figure 39. Europe RNAi Medicine Market Size Market Share by Application in 2021

Figure 40. Germany RNAi Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 41. France RNAi Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 42. UK RNAi Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 43. Italy RNAi Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 44. Russia RNAi Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 45. Middle East & Africa RNAi Medicine Market Size Market Share by Region in 2021

Figure 46. Middle East & Africa RNAi Medicine Market Size Market Share by Type in 2021

Figure 47. Middle East & Africa RNAi Medicine Market Size Market Share by Application in 2021

Figure 48. Egypt RNAi Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 49. South Africa RNAi Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 50. Israel RNAi Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 51. Turkey RNAi Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 52. GCC Country RNAi Medicine Market Size Growth 2017-2022 ($ Millions)

Figure 53. Americas RNAi Medicine Market Size 2023-2028 ($ Millions)

Figure 54. APAC RNAi Medicine Market Size 2023-2028 ($ Millions)

Figure 55. Europe RNAi Medicine Market Size 2023-2028 ($ Millions)

Figure 56. Middle East & Africa RNAi Medicine Market Size 2023-2028 ($ Millions)

Figure 57. United States RNAi Medicine Market Size 2023-2028 ($ Millions)

Figure 58. Canada RNAi Medicine Market Size 2023-2028 ($ Millions)

Figure 59. Mexico RNAi Medicine Market Size 2023-2028 ($ Millions)

Figure 60. Brazil RNAi Medicine Market Size 2023-2028 ($ Millions)

Figure 61. China RNAi Medicine Market Size 2023-2028 ($ Millions)

Figure 62. Japan RNAi Medicine Market Size 2023-2028 ($ Millions)

Figure 63. Korea RNAi Medicine Market Size 2023-2028 ($ Millions)

Figure 64. Southeast Asia RNAi Medicine Market Size 2023-2028 ($ Millions)

Figure 65. India RNAi Medicine Market Size 2023-2028 ($ Millions)

Figure 66. Australia RNAi Medicine Market Size 2023-2028 ($ Millions)

Figure 67. Germany RNAi Medicine Market Size 2023-2028 ($ Millions)

Figure 68. France RNAi Medicine Market Size 2023-2028 ($ Millions)

Figure 69. UK RNAi Medicine Market Size 2023-2028 ($ Millions)

Figure 70. Italy RNAi Medicine Market Size 2023-2028 ($ Millions)

Figure 71. Russia RNAi Medicine Market Size 2023-2028 ($ Millions)

Figure 72. Spain RNAi Medicine Market Size 2023-2028 ($ Millions)

Figure 73. Egypt RNAi Medicine Market Size 2023-2028 ($ Millions)

Figure 74. South Africa RNAi Medicine Market Size 2023-2028 ($ Millions)

Figure 75. Israel RNAi Medicine Market Size 2023-2028 ($ Millions)

Figure 76. Turkey RNAi Medicine Market Size 2023-2028 ($ Millions)

Figure 77. GCC Countries RNAi Medicine Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450